$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Can Apremilast (Otelal) be taken with food and the best time to take it?
2026-02-01 22:25:32
Check Details
Does the dosage of Valganciclovir need to be adjusted in elderly patients and what precautions should be taken
2026-02-01 22:25:32
Check Details
Why do some doctors not recommend taking Pitolisant?
2026-02-01 22:25:32
Check Details
Detailed description of safety and contraindications for use of Pretomanid in special populations
2026-02-01 22:25:32
Check Details
The efficacy and role of voclosporin and the safety and precautions for long-term use
2026-02-01 22:25:32
Check Details
Detailed explanation of common side effects of ponatinib and long-term medication safety guidelines
2026-02-01 22:25:32
Check Details
Reasons for facial edema after taking Shafinamide Tablets (Siddaco) for three days and medication safety tips
2026-02-01 22:25:32
Check Details
Tarlatamab-Imdelltra is a drug developed by which company?
2026-02-01 22:25:32
Check Details
Analysis and explanation of telisotuzumab-EMRELIS injection course and clinical usage plan
2026-02-01 22:25:32
Check Details
What grade of drug does tovorafenib belong to and its clinical value in targeted therapy
2026-02-01 22:25:32
Check Details
The efficacy and role of vorasidenib-VORANIGO and analysis of different patients’ experience and efficacy
2026-02-01 22:25:32
Check Details
Zongatinib (Zongatinib) price and reference cost in 2025
2026-02-01 22:25:32
Check Details
1
2
...
2266
2267
2268
2269
2270
2271
2272
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma